Table 1.
General characteristics of the study population (n = 182).
Table 2.
Classification of patients by BSI versus FACED (2A) or Exa-FACED (2B) scores, and FACED versus Exa-FACED (2C) scores.
(Total N = 182)
Table 3.
Comparison of BSI and FACED according to their components (n = 182).
Fig 1.
ROC curve for ≥2 exacerbations at 1-year of follow-up.
Abbreviations: Sens = sensitivity; Spec = specificity; PPV = positive predictive value; NPV = negative predictive value; GV: global value; LR+ = positive likelihood ratio; LR- = negative likehood ratio; OR = odds ratio; NA = non-available.
Fig 2.
ROC curve for ≥1 hospitalizations at 1-year of follow-up.
Abbreviations: Sens = sensitivity; Spec = specificity; PPV = positive predictive value; NPV = negative predictive value; GV: global value; LR+ = positive likelihood ratio; LR- = negative likelihood ratio; OR = odds ratio; NA = non-available.
Table 4.
Univariate and multivariate analysis of variables associated with the risk of 2 or more exacerbations.
Table 5.
Exa-FACED score.